Aicardi–Goutières syndrome and the type I interferonopathies
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Dissection of the genetic basis of Aicardi-Goutières syndrome has highlighted a fundamental link between nucleic acid metabolism, innate immune sensors and type I interferon induction. This had led to the concept of the human interferonopathies as a broader set of Mendelian disorders in which a constitutive upregulation of type I interferon activity directly relates to disease pathology. Here, we discuss the molecular and cellular basis of the interferonopathies, their categorization, future treatment strategies and the insights they provide into normal physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR edits Alu RNA51, and gain of function mutations in MDA5 suggest that RNA-sensing mechanisms are involved in some AGS cases119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“Aicardi–Goutières syndrome (AGS) is a childhood encephalopathy with similarities to SLE and strong IFN-I induction119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“In fact, hypocomplementia is a common feature of type I interferonopathies66,67”
From Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) · cites this paper as [66]
In the citing paper
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R‐loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
In the citing paper
“AGS is caused by mutations in genes that regulate nucleic acid metabolism.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
Citations
Cites
1 retracted
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.-D., Wang, J., Choi, J. H., Wang, K.-W., Purrington, T., et al. (2014) · Science · doi:10.1126/science.346.6216.1486 · Cited by 112
RetractedMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationImmune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Research works printed but not linked: 1
- Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
Cited by
Items 301–400 of 931
Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx
Vanderboom, P. M., Mun, D., Madugundu, A. K., Mangalaparthi, K. K., Saraswat, M., Garapati, K., Chakraborty, R., Ebihara, H., Sun, J., & Pandey, A. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100134 · Cited by 42
Antiviral immunity triggered by infection-induced host transposable elements
Hale, B. G. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.12.006 · Cited by 49
Inhibitory targeting cGAS-STING-TBK1 axis: Emerging strategies for autoimmune diseases therapy
Zhang, M., Zou, Y., Zhou, X., & Zhou, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954129 · Cited by 50
“Human cGAS is a 60 kD protein from the nucleotidyl transferase (NTase) family, consisting of a non-conserved Nterminal structural domain (1-160) and a highly conserved Cterminal NTase structural domain (161-522) (Figure 1A) (24).”
BackgroundSTING Contributes to Abnormal Bone Formation Induced by Deficiency of DNase II in Mice
Baum, R., Sharma, S., Organ, J. M., Jakobs, C., Hornung, V., Burr, D. B., Marshak‐Rothstein, A., Fitzgerald, K. A., & Gravallese, E. M. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39863 · Cited by 40
Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs
Achleitner, M., Kleefisch, M., Hennig, A., Peschke, K., Polikarpova, A., Oertel, R., Gabriel, B., Schulze, L., Lindeman, D., Gerbaulet, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700714 · Cited by 49
“triggers lupus-like systemic autoimmunity (1, 2) resulting in destructive CNS inflammation (3).”
BackgroundAditi, Downing, S. M., Schreiner, P. A., Kwak, Y. D., Li, Y., Shaw, T. I., Russell, H. R., & McKinnon, P. J. (2021) · Neuron · doi:10.1016/j.neuron.2021.09.040 · Cited by 40
A genome-wide optical pooled screen reveals regulators of cellular antiviral responses
Carlson, R. J., Leiken, M. D., Guna, A., Hacohen, N., & Blainey, P. C. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210623120 · Cited by 39
“Among putative negative regulators nominated by the screen was the Ragulator complex ( LAMTOR2,3,5 and associated genes FLCN and RRAGC) , which is required for mTOR activation (31) and whose activity was found to increase SeV load (Fig.”
Interferonopathies: From concept to clinical practice
Mendonça, L. O., & Frémond, M. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101975 · Cited by 48
Central tolerance to self revealed by the autoimmune regulator
Chan, A. Y. K., & Anderson, M. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12960 · Cited by 52
Tonduti, D., Orcesi, S., Jenkinson, E. M., Dorboz, I., Renaldo, F., Panteghini, C., Rice, G., Henneke, M., Livingston, J. H., Elmaleh, M., et al. (2016) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.03.009 · Cited by 39
Self-citationLoss of function of PCDH12 underlies recessive microcephaly mimicking intrauterine infection
Aran, A. A., Rosenfeld, N., Jaron, R., Renbaum, P., Zuckerman, S., Fridman, H., Zeligson, S., Segel, R., Kohn, Y., Kamal, L., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002704 · Cited by 42
“Similarly, mice null for TREX1, SAMHD1, IFIH1, or OCLN have neither structural nor functional neurologic deficits.(34,35) A likely explanation for the lack of phenotypic correlation between the human disease and the corresponding murine knockouts is differing tissue specificity in expression patterns of the various pr…”
BackgroundDNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice
Sakai, T., Miyazaki, T., Shin, D.-M., Kim, Y., Qi, C., Fariss, R. N., Munasinghe, J., Wang, H., Kovalchuk, A. L., Kothari, P. H., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.03.001 · Cited by 43
“However, not all C-terminal truncations are associated with RVCL with some being found in individuals diagnosed with SLE [1].”
BackgroundInfluentialThe Replication Stress Response on a Narrow Path Between Genomic Instability and Inflammation
Técher, H., & Pasero, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702584 · Cited by 40
“As it is the case for DSB end resection, the exonuclease activity of MRE11 is stimulated by its interaction with CtIP and SAMHD1 (Daddacha et al., 2017; Coquel et al., 2018).”
BackgroundInfluentialPinilla-Vera, M., Xiong, Z., Zhao, Y., Zhao, J., Donahoe, M. P., Barge, S., Horne, W. T., Kolls, J. K., McVerry, B. J., Birukova, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159329 · Cited by 36
“Indeed, monogenic disorders such as Aicardi-Goutières syndrome and type I interferonopathies bring attention to the tight regulation required to control type I interferon response and prevent auto-inflammatory diseases in humans [49].”
BackgroundSmall molecules targeting cGAS-STING pathway for autoimmune disease
Zhao, J., Xiao, R., Zeng, R., He, E., & Zhang, A. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114480 · Cited by 42
Telomeres as hotspots for innate immunity and inflammation
Nassour, J., Przetocka, S., & Karlseder, J. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103591 · Cited by 42
“Dysregulation of this pathway can contribute to the development of type I interferonopathies, such as Aicardi-Goutières syndrome (AGS) [128] and systemic lupus erythematosus (SLE) [129], characterized by a chronic activation of cGAS-STING and excessive IFN production.”
BackgroundZFR coordinates crosstalk between RNA decay and transcription in innate immunity
Haque, N., Ouda, R., Chen, C., Ozato, K., & Hogg, J. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03326-5 · Cited by 38
Giaglis, S., Daoudlarian, D., Voll, R. E., Kyburz, D., Venhoff, N., & Walker, U. A. (2021) · RMD Open · doi:10.1136/rmdopen-2021-002010 · Cited by 44
Consequences of chromosome gain: A new view on trisomy syndromes
Krivega, M., Stiefel, C. M., & Štorchová, Z. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.10.014 · Cited by 44
How RNA modifications regulate the antiviral response
Thompson, M. G., Sacco, M. T., & Horner, S. M. (2021) · Immunological Reviews · doi:10.1111/imr.13020 · Cited by 40
TMEFF1 is a neuron-specific restriction factor for herpes simplex virus
Dai, Y., Idorn, M., Serrero, M. C., Pan, X., Thomsen, E. A., Narita, R., Maimaitili, M., Qian, X., Iversen, M. B., Reinert, L. S., et al. (2024) · Nature · doi:10.1038/s41586-024-07670-z · Cited by 38
“For instance, although the type I IFN system is central for control of HSV-1 replication in the brain 9–12 , excessive IFN activity leads to pathology as illustrated in Aicardi–Goutières syndrome 2 .”
Ebstein, F., Küry, S., Most, V., Rosenfelt, C., Scott-Boyer, M.-P., van Woerden, G. M., Besnard, T., Papendorf, J. J., Studencka-Turski, M., Wang, T., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo3189 · Cited by 36
“The lack of systemic autoinflammation in patients with NDD/ID and PSMC3 variants mounting a constitutive type I IFN response may seem surprising at first sight, but it is not totally unexpected, because this inconsistency is found in other NDDs, including Aicardi-Goutières (75, 76) and Down syndrome (77, 78).”
BackgroundInfluentialCesaro, T., Hayashi, Y., Borghese, F., Vertommen, D., Wavreil, F., & Michiels, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-88610-z · Cited by 37
Chilblains in immune-mediated inflammatory diseases: a review
Dubey, S., Joshi, N., Stevenson, O., Gordon, C., & Reynolds, J. A. (2022) · Rheumatology · doi:10.1093/rheumatology/keac231 · Cited by 36
Jean-Baptiste, V. S. E., Xia, C., Clare-Salzler, M. J., & Horwitz, M. S. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.06.014 · Cited by 39
“Of particular relevance to T1D are mutations in IFIH1which encodes the intracellular pattern recognition receptor (PRR), melanoma differentiation-associated protein 5 (MDA5).”
BackgroundInfluentialInterstitial Lung Disease and Psoriasis in a Child With Aicardi-Goutières Syndrome
Zheng, S., Lee, P. Y., Wang, J., Wang, S., Huang, Q., Huang, Y., Liu, Y., Zhou, Q., & LI, T. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00985 · Cited by 36
“Primary manifestations of AGS include progressive developmental decline, encephalopathy, cerebral calcification,muscle weakness, or spasticity, and variable features of autoimmunity ranging from the presence of autoantibodies to full-blown presentation of systemic lupus erythematosus (SLE) (2).”
BackgroundErazo-Martínez, V., Tobón, G. J., & Cañas, C. A. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103262 · Cited by 38
White, T. E., Brandariz-Núñez, A., Martínez‐López, A., Knowlton, C., Lenzi, G. M., Kim, B., Ivanov, D. N., & Diaz‐Griffero, F. (2017) · Human Mutation · doi:10.1002/humu.23201 · Cited by 37
“AGS is considered an interferonopathie in which upregulation of type I IFN activity directly correlates with disease progression (Crow & Manel, 2015).”
BackgroundChanges in the biochemical taste of cytoplasmic and cell-free DNA are major fuels for inflamm-aging
Storci, G., Carolis, S. D., Olivieri, F., & Bonafè, M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.08.003 · Cited by 38
Guo, X., Liu, S., Sheng, Y., Zenati, M., Billiar, T. R., Herbert, A. G., & Wang, Q. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112733 · Cited by 39
“26 ADAR1 knockout Adar +/− mice were prepared via homologous recombination that deleted Exon 12–15 as described previously.”
ADAR1 is vital for B cell lineage development in the mouse bone marrow
Marcu‐Malina, V., Goldberg, S., Vax, E., Amariglio, N., Goldstein, I., & Rechavi, G. (2016) · Oncotarget · doi:10.18632/oncotarget.11029 · Cited by 36
“Similarly, infants with mutated ADAR1 develop during early life a severe interferonopathy, the Aicardi-Goutières syndrome (AGS), presenting with encephalopathy and features akin with systemic lupus erythematosus (SLE) and congenital viral infections [13-16].”
BackgroundReynolds, J. A., Briggs, T. A., Rice, G., Darmalinggam, S., Bondet, V., Bruce, E. S., Khan, M., Haque, S., Chinoy, H., Herrick, A. L., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1929-4 · Cited by 36
Novel Genetic Discoveries in Primary Immunodeficiency Disorders
Redmond, M. T., Scherzer, R., & Prince, B. T. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08881-2 · Cited by 39
“1 3 acquired microcephaly, and a rapid course toward profound deterioration and death,” pathogenic variants in several genes that lead to upregulation of type I INFs have been described to cause an AGS-like phenotype [85].”
Endogenous retroelements as alarms for disruptions to cellular homeostasis
Lindholm, H. T., Chen, R. E., & Carvalho, D. D. D. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.09.001 · Cited by 38
Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification
Gollmann‐Tepeköylü, C., Graber, M., Hirsch, J., Mair, S., Naschberger, A., Pölzl, L., Nägele, F., Kirchmair, E., Degenhart, G., Demetz, E., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.063481 · Cited by 37
Ullah, T. R., Johansen, M. D., Balka, K. R., Ambrose, R. L., Gearing, L. J., Roest, J., Vivian, J. P., Sapkota, S., Jayasekara, W. S. N., Wenholz, D. S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41381-9 · Cited by 38
“While normally protective against viral infection, TBK1-driven IRF3 transcription can also fuel viral-driven hyperin fl ammation and auto-immune diseases arising from aberrant engagement of STING, TRIF, or MAVS 2,3 .”
BackgroundThe role of RNA editing by ADAR1 in prevention of innate immune sensing of self-RNA
Heraud-Farlow, J. E., & Walkley, C. R. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1416-1 · Cited by 37
“protein 1 (IFIH1, also known as MDA5) [1].”
BackgroundHIV replication: a game of hide and sense
Sauter, D., & Kirchhoff, F. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000233 · Cited by 41
“Mutations in the respective genes are all associated with Aicardi-Goutières syndrome (AGS), a rare disease characterized by increased immune activation and IFN production [56].”
BackgroundLTR-retrotransposon transcriptome modulation in response to endotoxin-induced stress in PBMCs
Mommert, M., Tabone, O., Oriol, G., Cerrato, E., Guichard, A., Naville, M., Fournier, P., Volff, J., Pachot, A., Monneret, G., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4901-9 · Cited by 38
“From an in vivo point of view, this approach paves the way for systematic deciphering of modulated retroviral elements associated with autoimmune diseases such as systemic lupus erythematosus, inflammatory diseases such as type 1 diabetes [79] inherited autoimmune and auto-inflammatory disorders such as type 1 interfe…”
BackgroundKorvatska, O., Kiianitsa, K., Ratushny, A., Matsushita, M., Beeman, N., Chien, W.-M., Satoh, J.-I., Dorschner, M. O., Keene, C. D., Bammler, T. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559342 · Cited by 33
“In the absence of viral infection, unchecked IFN I response is harmful, being a cause of Aicardi–Goutières syndrome (AGS), a group of monogenic interferonopathies that affect the CNS (58).”
BackgroundConceptus interferon gamma is essential for establishment of pregnancy in the pig
Johns, D. N., Lucas, C. G., Pfeiffer, C. A., Chen, P. R., Meyer, A. E., Perry, S. D., Spate, L. D., Cecil, R. F., Fudge, M. A., Samuel, M., et al. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab186 · Cited by 36
“Elevated type I IFN levels during pregnancy may be pathogenic as seen in diseases that increase the production of type I IFN leading to miscarriage [6, 51].”
BackgroundZhang, X., Han, L., Hou, J., Yang, H., Xu, H., Li, G., Shu, Q., Zhu, D., Zheng, Y., & Gao, C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114248 · Cited by 46
Activation and regulation of cGAS-STING signaling in cancer cells
Shim, A., Chen, Y., & Maciejowski, J. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.08.030 · Cited by 38
Dawn of Epitranscriptomic Medicine
Gatsiou, A., & Stellos, K. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001927 · Cited by 32
The central role of nucleic acids in the pathogenesis of systemic lupus erythematosus
Pisetsky, D. S. (2019) · F1000Research · doi:10.12688/f1000research.17959.1 · Cited by 33
Update on the pathogenesis of central nervous system lupus
Nikolopoulos, D., Fanouriakis, A., & Boumpas, D. T. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000655 · Cited by 33
Wu, T., Gao, J., Liu, W., Cui, J., Yang, M., Guo, W., & Wang, F. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115495 · Cited by 31
Recent advances in the activation and regulation of the cGAS-STING pathway
Fang, R., Jiang, Q., Yu, X., Zhao, Z., & Jiang, Z. (2022) · Advances in immunology · doi:10.1016/bs.ai.2022.09.003 · Cited by 32
Secreted mammalian DNases protect against systemic bacterial infection by digesting biofilms
Lacey, K. A., Serpas, L., Makita, S., Wang, Y., Rashidfarrokhi, A., Soni, C., González, S. M., Moreira, A. L., Torres, V. J., & Reizis, B. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221086 · Cited by 34
The phenotype of the most common human ADAR1p150 Zα mutation P193A in mice is partially penetrant
Liang, Z., Chalk, A. M., Taylor, S., Goradia, A., Heraud-Farlow, J. E., & Walkley, C. R. (2023) · EMBO Reports · doi:10.15252/embr.202255835 · Cited by 34
“AGS is an inherited paediatric encephalopathy, classed as an auto-inflammatory “Type I interferonopathy,” characterised by the upregulation of interferon (IFN) and interferon-stimulated gene (ISG) expression (Crow & Manel, 2015).”
Casazza, R. L., Philip, D. T., & Lazear, H. M. (2022) · mBio · doi:10.1128/mbio.03857-21 · Cited by 32
Guo, X., Steinman, R. A., Sheng, Y., Cao, G., Wiley, C. A., & Wang, Q. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02646-0 · Cited by 33
“The notable biochemical feature of AGS is a type 1 IFN “signature” of elevated expression of interferon-stimulated genes (ISGs) detected in the cerebral spinal fluid and blood [7, 8, 11].”
BackgroundInfluentialA dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
Wing, P. A. C., Davenne, T., Wettengel, J. M., Lai, A. G., Zhuang, X., Chakraborty, A., D’Arienzo, V., Kramer, C., Ko, C., Harris, J. M., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900355 · Cited by 31
“Mutations in SAMHD1 are implicated in cancer development (Mauney & Hollis, 2018) and in a severe congenital in fl ammatory disease known as Aicardi – Goutie ̀ res syndrome that is characterized by an overproduction of type I IFNs (Crow & Manel, 2015).”
Dong, X., Tan, N. B., Howell, K. B., Barresi, S., Freeman, J. L., Vecchio, D., Piccione, M., Radio, F. C., Calame, D. G., Zong, S., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.02.014 · Cited by 32
“There are several hypotheses to explain calcium deposition in the brain; these hypotheses include abnormal calcium metabolism,(31) microangiopathy,(32) and inflammation.(33) ICC has not yet been examined inNrros knockoutmice.”
BackgroundInborn errors of immunity—recent advances in research on the pathogenesis
Yamashita, M., Inoue, K., Okano, T., & Morio, T. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-021-00159-6 · Cited by 38
“An example of this entity is AicardiGoutieres syndrome that is characterized by calcification, demyelination, and brain atrophy [20].”
BackgroundPapendorf, J. J., Krüger, E., & Ebstein, F. (2022) · Cells · doi:10.3390/cells11091422 · Cited by 39
Struja, T., Kutz, A., Fischli, S., Meier, C., Müeller, B., Recher, M., & Schüetz, P. (2017) · BMC Medicine · doi:10.1186/s12916-017-0939-9 · Cited by 31
“The link of type I IFNs to AID is most strikingly demonstrated in a subgroup of monogenic PIDs that share an overexpression of IFN-regulated genes, the so-called interferonopathies [49].”
BackgroundSAMHD1 deficient human monocytes autonomously trigger type I interferon
Martínez‐López, A., Martín-Fernández, M., Buta, S., Kim, B., Bogunovic, D., & Diaz‐Griffero, F. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.08.005 · Cited by 32
“the auto-inflammatory Aicardi-Goutieres syndrome (AGS), which mimics congenital infection and is manifested by increased production of type I interferon (IFN) (Crow et al., 2006a; Crow and Manel, 2015; Dale et al., 2010; du Moulin et al., 2011; Kretschmer and Lee-Kirsch, 2017; Leshinsky-Silver et al., 2011; Livingston…”
A 44‐year‐old man with eye, kidney, and brain dysfunction
Vodopivec, I., Oakley, D. H., Perugino, C. A., Venna, N., Hedley‐Whyte, E. T., & Stone, J. H. (2015) · Annals of Neurology · doi:10.1002/ana.24583 · Cited by 32
“The aberrant endogenous nucleic acids can upregulate type I IFN signaling through binding to a DNA sensor cyclic guanosine monophosphate–adenosine monophosphate synthase (cGAS) in a manner similar to that of viral DNA.26 TREX1 thus functions as a negative regulator of IFNstimulatory DNA responses.27 To date, only 12 f…”
BackgroundEffects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures
Fisher, A. J., & Beal, P. A. (2016) · RNA Biology · doi:10.1080/15476286.2016.1267097 · Cited by 33
“AGS is a severe childhood autoimmune disease that has a genetic basis but also clinical and biochemical similarities to congenital infection.(22,23) It is one of a broader set of inherited disorders characterized by constitutive upregulation of type I interferon (IFN) (i.”
BackgroundNeurodegenerative diseases have genetic hallmarks of autoinflammatory disease
Richards, R. I., Robertson, S. A., & Kastner, D. L. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy139 · Cited by 29
Delgado-Vega, A. M., Martínez‐Bueno, M., Oparina, N. Y., Herráez, D. L., Kristjansdottir, H., Steinsson, K., Kozyrev, S. V., & Alarcón-Riquelme, M. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-26274-y · Cited by 32
Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease
Beck, D. B., & Aksentijevich, I. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00101 · Cited by 29
“The underlying mechanism of inflammation in monogenic interferonopathies is a defect in sensing and degradation of nucleic acids leading to constitutive activation of innate immune responses (126, 127).”
BackgroundType 1 Interferon in the Human Intestine—A Co-ordinator of the Immune Response to the Microbiota
Giles, E. M., & Stagg, A. J. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001078 · Cited by 33
Crucial Roles of RSAD2/viperin in Immunomodulation, Mitochondrial Metabolism and Autoimmune Diseases
Chen, S., Ye, J., Lin, Y., Chen, W., Huang, S., Yang, Q., Qian, H., Gao, S., & Hua, C. (2024) · Inflammation · doi:10.1007/s10753-024-02076-5 · Cited by 31
ADAR1 Regulates Early T Cell Development via MDA5-Dependent and -Independent Pathways
Vongpipatana, T., Nakahama, T., Shibuya, T., Kato, Y., & Kawahara, Y. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900929 · Cited by 30
Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus
Robinson, S., & Thomas, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654701 · Cited by 31
Manet, C., Mansuroglu, Z., Conquet, L., Bortolin, V., Comptdaer, T., Segrt, H., Bourdon, M., Menidjel, R., Stadler, N., Tian, G., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02668-8 · Cited by 30
Popova, G., Retallack, H., Kim, C. N., Wang, A., Shin, D. S., DeRisi, J. L., & Nowakowski, T. J. (2023) · eLife · doi:10.7554/elife.87696 · Cited by 32
“The interferon response is additionally associated with pathobiology in a range of congenital infections and interferonopathies (Crow and Manel, 2015).”
BackgroundAn Integrative Framework Reveals Signaling-to-Transcription Events in Toll-like Receptor Signaling
Mertins, P., Przybylski, D., Yosef, N., Qiao, J., Clauser, K. R., Raychowdhury, R., Eisenhaure, T., Maritzen, T., Haucke, V., Satoh, T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.016 · Cited by 30
“…and Este´, 2015), but it also plays a role in processes such as TNF-mediated pro-inflammatory signaling in fibroblasts (Liao et al., 2008), cell cycle (Pauls et al., 2014), or DNA damage (Clifford et al., 2014) and in disease such as AGS (Crow and Manel, 2015) and cancer (Schuh et al., 2012).”
BackgroundGenetically defined autoinflammatory diseases
de Jesus, A., & Goldbach‐Mansky, R. T. (2016) · Oral Diseases · doi:10.1111/odi.12448 · Cited by 29
The Interplay Among HIV, LINE-1, and the Interferon Signaling System
Zhao, X., Zhao, Y., Du, J., Gao, P., & Zhao, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732775 · Cited by 36
“AGS was soon found to be an autosomal recessive disorder, and several genes that are associated with AGS have been identified since [refer to (62) for additional details].”
BackgroundChemical regulation of the cGAS-STING pathway
Zhang, Q., Chen, C., Xia, B., & Xu, P. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102170 · Cited by 27
How to Build a Fire: The Genetics of Autoinflammatory Diseases
Zhang, J., Lee, P. Y., Aksentijevich, I. A., & Zhou, Q. (2023) · Annual Review of Genetics · doi:10.1146/annurev-genet-030123-084224 · Cited by 30
Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases
Orecchini, E., Frassinelli, L., Galardi, S., Ciafrè, S. A., & Michienzi, A. (2018) · Chromosome Research · doi:10.1007/s10577-018-9572-5 · Cited by 31
Monogenic systemic lupus erythematosus: insights in pathophysiology
Batu, E. D. (2018) · Rheumatology International · doi:10.1007/s00296-018-4048-7 · Cited by 34
Stankiewicz-Isidor syndrome: expanding the clinical and molecular phenotype
Isidor, B., Ebstein, F., Hurst, A., Vincent, M., Bader, I., Rudy, N. L., Cogne, B., Mayr, J., Brehm, A., Bupp, C., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2021.09.005 · Cited by 24
Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity
Jarmoskaite, I., & Li, J. B. (2024) · RNA · doi:10.1261/rna.079953.124 · Cited by 28
“Both ADAR1 and MDA5 mutations have been linked to the rare neurodevelopmental disease Aicardi – Goutières syndrome (AGS), which can also be caused by mutations in other genes involved in nucleic acid sensing (Crow et al. 2015).”
BackgroundInfluentialTargeting STING oligomerization with licochalcone D ameliorates STING-driven inflammatory diseases
Zhang, Y., Liu, Y., Jiang, B., Chen, L., Hu, J., Niu, B., Chang, J., Fan, Z., Zhou, J., Wang, Y., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2703-6 · Cited by 30
“People with these mutations may develop into Aicardi-Goutières syndrome (AGS) or systemic lupus erythematosus (SLE) (Crow and Manel, 2015; Gray et al., 2015; Rodero et al., 2017).”
Systemic Lupus Erythematosus: Is It One Disease?
Rivas‐Larrauri, F., & Yamazaki‐Nakashimada, M. A. (2016) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2016.01.002 · Cited by 28
Masanneck, L., Eichler, S., Vogelsang, A., Korsen, M., Wiendl, H., Budde, T., & Meuth, S. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239249 · Cited by 26
“These include, for example, the severe Aicardi-Goutières syndrome, which is associated with a cerebral overproduction of IFN-α [28,29], thus underlining the need for tight regulation of responses.”
BackgroundMitochondrial RNA , a new trigger of the innate immune system
Grochowska, J., Czerwińska, J., Borowski, L. S., & Szczęsny, R. J. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1690 · Cited by 33
“One of these, AGS, is a rare, inflammatory neurodevelopmental disorder (Crow & Manel, 2015).”
BackgroundInfluentialInoue, M., Nakahama, T., Yamasaki, R., Shibuya, T., Kim, J. I., Todo, H., Xing, Y., Kato, Y., Morii, E., & Kawahara, Y. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100526 · Cited by 26
Brain Calcifications in Adult-Onset Genetic Leukoencephalopathies: A Review
Ayrignac, X., Nicolas, G., Dalliere, C. C., Hannequin, D., & Labauge, P. M. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1062 · Cited by 29
De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS
Zhao, W., Chen, G., He, J., Shen, X., Xiong, M., Xiong, L., Qi, Z., Xie, H., Li, W., Li, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60297-0 · Cited by 28
“…of many diseases, includ-ingAicardi-Goutièressyndrome,autoimmunedisorders,in fl ammatory conditions, neurodegenerative diseases, aging, and COVID-19 4 – 8 . cGAS inactivation achieved genetically or pharmacologically consistently mitigates disease progression in diverse animal models in…”
Innate Antiviral Defenses Independent of Inducible IFNα/β Production
Paludan, S. R. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.003 · Cited by 29
Taneja, V., Goel, M., Shankar, U., Kumar, A., Khilnani, G. C., Prasad, H. K., Prasad, G. B. K. S., Gupta, U. D., & Sharma, T. K. (2020) · ACS Combinatorial Science · doi:10.1021/acscombsci.0c00108 · Cited by 25
The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
Raftopoulou, S., Rapti, A., Karathanasis, D., Evangelopoulos, M., & Mavragani, C. P. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1026449 · Cited by 26
Chanut, R., & Pétrilli, V. (2019) · médecine/sciences · doi:10.1051/medsci/2019095 · Cited by 30
Tam, O. H., Rozhkov, N. V., Shaw, R., Kim, D., Hubbard, I., Fennessey, S., Propp, N., The NYGC ALS Consortium, Fagegaltier, D., Ostrow, L. W., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/574509 · Cited by 25
Du, Y., Liu, M., Nigrovic, P. A., Dedeoğlu, F., & Lee, P. Y. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.816 · Cited by 24
Guarnieri, J. W., Topper, M. J., Beigel, K., Haltom, J., Chadburn, A., Frere, J. J., An, J., Cope, H., Borczuk, A., Sinha, S., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2401968121 · Cited by 34
RNA sensing induced by chromosome missegregation augments anti-tumor immunity
Sasaki, N., Homme, M., Murayama, T., Osaki, T., Tenma, T., An, T., Takegami, Y., Tani, T., Gedeon, P. C., Kobayashi, Y., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.11.025 · Cited by 35
Novel monogenic diseases causing human autoimmunity
Melki, I., & Crow, Y. J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.07.008 · Cited by 24
Self-citationChudnovets, A., Lei, J., Na, Q., Dong, J., Narasimhan, H., Klein, S. L., & Burd, I. D. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13248 · Cited by 28
Aicardi–Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5
Onizawa, H., Kato, H., Kimura, H., Kudo, T., Soda, N., Shimizu, S., Funabiki, M., Yagi, Y., Nakamoto, Y., Priller, J., et al. (2020) · International Immunology · doi:10.1093/intimm/dxaa073 · Cited by 23
Retroelement-derived RNA and its role in the brain
Evans, T. A., & Erwin, J. A. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.11.001 · Cited by 27
Pharmacological insights into autophagy modulation in autoimmune diseases
Wu, M.-Y., Wang, E., Feng, D., Li, M., Ye, R. D., & Lu, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.026 · Cited by 25
Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation
Cattalini, M., Galli, J., Zunica, F., Ferraro, R. M., Carpanelli, M., Orcesi, S., Palumbo, G., Pinelli, L., Giliani, S., Fazzi, E. M., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.725868 · Cited by 25
“Type I interferonopathies constitute a recently identified group of Mendelian autoinflammatory diseases characterized by an aberrant and uncontrolled activation of the IFN-alpha pathway leading to multisystemic involvement in the first years of life (1).”
BackgroundIntracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis
Ohto, T., Tayeh, A. A., Nishikomori, R., Abe, H., Hashimoto, K., Baba, S., Arias-Loza, P.-A., Soda, N., Satoh, S., Matsuda, M., et al. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102794 · Cited by 27
Metadata
- Authors
- Crow, Y. J., & Manel, N.
- Affiliations
- Inserm (FR)
- Corresponding author
- Crow, Yanick J.
- Venue
- Nature Reviews Immunology
- Published
- 2015-06-05
- Volume
- 15
- Issue
- 7
- Pages
- 429-440
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1542158376
- Cited by
- 925
- References
- 106
- Citations by year
- 2026: 63 · 2025: 80 · 2024: 83 · 2023: 92 · 2022: 103 · 2021: 92 · 2020: 82 · 2019: 80 · 2018: 71 · 2017: 88 · 2016: 75 · 2015: 16
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IDEX-0001, ANR-11-LABX-0043)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Aicardi-Goutières syndrome, type I interferonopathy, type I interferon, innate immune signaling, monogenic disorders, nucleic acid metabolism, innate immune sensors, interferon induction, interferonopathies, treatment options
- MeSH terms
- Animals, Humans, Interferon Type I, Nervous System Malformations, Autoimmune Diseases of the Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.